Overview
Jorge Calderon is a General Surgeon practicing medicine in Halethorpe, Maryland.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
4000 Annapolis Rd Ste 201, Halethorpe, MD 21227
Johns Hopkins Outpatient Center
Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. He is board certified in American Board Of Surgery. Dr. He is currently accepting new patients.
Johns Hopkins Outpatient Center
Dr. Cameron has had a long and distinguished career in alimentary tract diseases and specifically in pancreatic cancer. He has won worldwide acclaim for mastering the Whipple procedure. At the beginning of his career, the mortality rate from the Whipple procedure was nearly 30 percent. He has worked to lower that to 1 percent to 2 percent at Johns Hopkins. He has operated on more patients with pancreatic cancer and done more Whipple resections than any other surgeon in the world. In addition to maintaining a busy practice that focuses mainly on pancreatic surgery, he has been a leader in the surgical profession, serving as president of the American College of Surgeons, Society for Surgery of the Alimentary Tract, Southern Surgical Association, Society of Clinical Surgery, Society of Surgical Chairmen, Halsted Society and American Surgical Association. He served as chief of surgery for The Johns Hopkins Hospital for nineteen years. Dr. Cameron obtained his undergraduate degree from Harvard University in 1958, and his medical degree from The Johns Hopkins University School of Medicine in 1962. All of his training in General and Thoracic Surgery was obtained at The Johns Hopkins Hospital. Dr. Cameron is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Cameron is board certified in American Board Of Thoracic Surgery and American Board Of Surgery. Dr. Cameron is currently accepting new patients.
Grace Medical Center
Pelayo Correa is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Correa is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Helicobacter Pylori Infection, Gastritis, and Chronic Erosive Gastritis.
UMMC Department Of Neurosurgery
Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, brain and spinal cord tumors, and traumatic brain injuries. He is the Principal Investigator for several multi-institution research studies, including: Hydrocephalus Clinical Research Network: currently investigating endoscopic surgery vs shunting for the treatment of hydrocephalus in infants in a $10M randomized trial funded by the NIH Park Reeves Syringomyelia Research Consortium Advancing the treatment for pediatric craniopharyngioma, identifying biological targets for molecular therapy A multi-institutional trial investigating a non-invasive eye tracking device for assessing increased intracranial pressure. Dr. Jackson is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Chiari Malformation Type 2, Chiari Malformation, Posterior Fossa Decompression, and Spinal Fusion. Dr. Jackson is board certified in American Board Of Neurological Surgery and American Board Of Neurological Surgery - Neurological Surgery, 2014. Dr. Jackson is currently accepting new patients.
Rubenstein Child Health Building
David J. Hackam, M.D., Ph.D., is the Garrett Family Professor of Pediatric Surgery at The Johns Hopkins University, and Pediatric Surgeon-in-Chief and co-Director of the Johns Hopkins Children’s Center. Dr. Hackam’s clinical practice focuses on complex neonatal surgery. As pediatric surgeon in chief and co-director of the Childrens Center, Dr. Hackam oversees all perioperative clinical operations that involve children, with a strong emphasis on quality and safety, programmatic growth, and system alignment. Dr. Hackam's research is focused on unraveling the mechanisms of necrotizing enterocolitis, which is the leading cause of death in premature infants from gastrointestinal disease. His work has identified a series of novel pathways that, in response to the abnormal microflora that characterizes the premature intestine, leads to intestinal mucosal barrier breakdown, bacterial translocation, mesenteric vasoconstriction, and NEC. In seeking to translate these findings to clinical studies, we have developed a family of molecules that can prevent NEC development, and which have in part been licensed for clinical development. In additional work, Hackam has developed a prototype artificial intestine, derived from patient-specific intestine stem cells, which we have implanted into pre-clinical models, for the treatment of short bowel syndrome, a devastating complication of NEC. Finally, using single-cell RNA-seq and cell tracking technology, Hackam has worked towards understanding and treating NEC-associated brain injury, a major complication of NEC, and has engineered nanoparticle-packaged molecules that can cross the blood-brain barrier, and reverse the processes that lead to this disease. These studies are funded by three ro1s, a T32, a MIRA (a maximizing investigators’ research award) and 3 industry grants from companies with an interest in NEC treatment and prevention. Dr. Hackam seeks to work with industry partners, as well as nurses, doctors, and families of patients around the country, in order to develop novel regimens to safely and effectively deliver appropriate nutrition to the most vulnerable infants, who are at risk for the development of intestinal disease. Dr. Hackam is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Necrotizing Enterocolitis, Necrosis, Short Bowel Syndrome, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Hackam is board certified in American Board Of Surgery. Dr. Hackam is currently accepting new patients.
Ascension Saint Agnes Breast Center
Kristen Fernandez, MD, is director of the Ascension Saint Agnes Breast Center in Baltimore and Columbia, Maryland. She is a board-certified general surgeon and specializes in breast cancer and benign breast disease. Dr. Fernandez provides breast conserving surgery, accelerated partial breast radiation and nipple sparing mastectomy. Dr. Fernandez helps you understand your treatment options and works with you to create a personalized care plan. Dr. Fernandez is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Fernandez is board certified in The American Board Of Surgery - General Surgery. Dr. Fernandez is currently accepting new patients.
Frequently Asked Questions about Dr. Jorge E. Calderon
How do I make an appointment with Dr. Jorge E. Calderon?
You can book an appointment with Dr. Jorge E. Calderon by calling their office at 410-636-2222. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Does Dr. Jorge E. Calderon accept my insurance?
Dr. Jorge E. Calderon accepts most major insurance plans, including Aetna. We recommend calling the office directly at 410-636-2222 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.




